Denosumab Treatment for Fibrous Dysplasia

Fibrous dysplasia (FD) is a skeletal disease caused by somatic activating mutations of the cAMP-regulating protein, G(s)α. These mutations lead to replacement of normal bone by proliferative osteogenic precursors, resulting in deformity, fracture, and pain. Medical treatment has been ineffective in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Boyce, AM, Chong, WH, Yao, J, Gafni, RI, Kelly, MH, Chamberlain, CE, Bassim, C, Cherman, N, Ellsworth, M, Kasa-Vubu, JZ, Farley, FA, Molinolo, AA, Bhattacharyya, N, Collins, MT
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3377825/
https://ncbi.nlm.nih.gov/pubmed/22431375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.1603
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items